Arbutus Biopharma Corporation ABUS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $169.7M+792% | -$3.76M+70.0% | -$7.74M+60.7% | $2.52M+113% | -$24.53M-37.2% | ||
| $11K-96.7% | $11K-96.7% | $11K-96.7% | $11K-96.9% | $330K-7.0% | ||
| $1.36M-61.9% | $1.26M-22.7% | $1.26M-41.5% | $864K-72.8% | $3.56M+77.0% | ||
| -$8.11M+39.4% | -$4.68M+54.6% | -$5.82M+71.9% | -$15.75M-8.6% | -$13.39M+30.6% | ||
| $2.2M-80.6% | —— | —— | $15.61M+58.8% | $11.35M-3.0% | ||
| $11.62M+317% | $1.64M+15.4% | $844K-52.5% | $453K-98.1% | $2.78M-88.6% | ||
| $5.7M+664% | -$4.4M-198% | -$15M— | $336K-98.3% | $746K-95.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arbutus Biopharma Corporation generate?
- Arbutus Biopharma Corporation (ABUS) generated -$34.4M in operating cash flow over the trailing twelve months.
- Where does Arbutus Biopharma Corporation's cash flow data come from?
- Every line is extracted from Arbutus Biopharma Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
